Hardy Diagnostics, in partnership with Autobio, has launched the Matrix-Assisted Laser Desorption/Ionized Time of Flight instrument.

The device, which is otherwise known as MALDI-TOF, offers high-speed detection and taxonomical classification of bacteria, yeasts and filamentous fungi based on proteomic fingerprinting.

The Autof MS 1000 has a database of approximately 5,000 species of microorganisms created with more than 15,000 strains.

As compared with conventional methods and PCR, the instrument has faster time-to-result and accuracy similar to nucleic acid sequencing technologies.

The Autof MS 1000 is a cost-effective, robust, intuitive software that can detect 96 samples with a hands-on time of fewer than 20 minutes.

The latest launch is an example of the expansion of Hardy Diagnostics’ product portfolio and further advancement of instrumentation for use in microbiology labs, the company noted.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Hardy Diagnostics chief scientific officer Andre Hsiung said: “We are very proud of our partnership with Autobio and the introduction of this technology to Hardy’s instrumentation offering.

“Initially, introduction will be made to markets that do not require FDA’s 510(k) clearance, while our regulatory team works on the studies pursuant to the clearance process.”

In various studies, the higher accuracy, faster time-to-result, and reduced cost of MALDI-TOF technology versus classical methods has been demonstrated.

Hardy Diagnostics CEO Jay Hardy said: “We are very excited to add the MALDI Autof MS 1000 to our lineup of instruments to streamline the processes for microbiologists.”

The company had previously unveiled automated Gram stain and automated Hematology stain instruments, air sampling, automated serial dilution, and automated plate reading instrumentation.

The MALDI technology is a method of soft ionisation, which lowers the amount of molecular fragmentation and preserves integrity of the sample.